Yunqin Lee

476 total citations
11 papers, 346 citations indexed

About

Yunqin Lee is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yunqin Lee has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Yunqin Lee's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Yunqin Lee is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Yunqin Lee collaborates with scholars based in United States, Singapore and Italy. Yunqin Lee's co-authors include John B. Sunwoo, June Ho Shin, Michelle Longmire, Hua Wang, Howard Y. Chang, Holbrook E. Kohrt, Subhra K. Biswas, Beverly S. Mitchell, Le Xuan Truong Nguyen and Manesh Chittezhath and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Cell Biology.

In The Last Decade

Yunqin Lee

11 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunqin Lee United States 7 198 151 123 51 28 11 346
Wenxin Wu China 9 139 0.7× 116 0.8× 90 0.7× 34 0.7× 9 0.3× 24 311
Ning Niu China 8 176 0.9× 29 0.2× 211 1.7× 53 1.0× 16 0.6× 17 669
Andrii I. Rozhok United States 14 176 0.9× 61 0.4× 294 2.4× 215 4.2× 11 0.4× 22 631
Ikumi Aoki Japan 13 149 0.8× 131 0.9× 221 1.8× 88 1.7× 16 0.6× 20 497
Nora Sommerfeldt Germany 8 267 1.3× 364 2.4× 100 0.8× 19 0.4× 24 0.9× 9 477
Ru Yao China 11 136 0.7× 20 0.1× 102 0.8× 152 3.0× 12 0.4× 39 375
Marcela Riveros Chile 5 80 0.4× 44 0.3× 238 1.9× 69 1.4× 30 1.1× 5 428
Koji Kanda Japan 11 126 0.6× 100 0.7× 197 1.6× 72 1.4× 2 0.1× 15 406
Phillip Liu United States 9 157 0.8× 51 0.3× 241 2.0× 30 0.6× 15 0.5× 16 468
Karilyn Larkin United States 9 85 0.4× 69 0.5× 153 1.2× 43 0.8× 3 0.1× 38 361

Countries citing papers authored by Yunqin Lee

Since Specialization
Citations

This map shows the geographic impact of Yunqin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunqin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunqin Lee more than expected).

Fields of papers citing papers by Yunqin Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunqin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunqin Lee. The network helps show where Yunqin Lee may publish in the future.

Co-authorship network of co-authors of Yunqin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yunqin Lee. A scholar is included among the top collaborators of Yunqin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunqin Lee. Yunqin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bufalo, Francesca Del, Pietro Merli, Daria Pagliara, et al.. (2024). CD7.Pebl-CART for Patients with Relapsed/Refractory (r/r) T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 144(Supplement 1). 4830–4830. 1 indexed citations
2.
Lee, Yunqin, et al.. (2022). Development of Anti-CD3 Chimeric Antigen Receptor (CAR)-T Cells for Allogeneic Cell Therapy of Peripheral T-Cell Lymphoma (PTCL). Blood. 140(Supplement 1). 4510–4511. 4 indexed citations
3.
Tan, Siqi, Yunqin Lee, Who-Whong Wang, et al.. (2018). Ex vivo co-culture models for immunotherapy with patient-derived tumor infiltrating lymphocytes, peripheral blood mononuclear cells and autologous patient colorectal cancer (CRC) cell lines.. Journal of Clinical Oncology. 36(15_suppl). e15531–e15531. 1 indexed citations
4.
Lee, Yunqin, et al.. (2017). Abstract 33: CEACAM1 blockade increases NK cell cytotoxicity in head and neck squamous cell carcinoma. Clinical Cancer Research. 23(23_Supplement). 33–33. 2 indexed citations
5.
Lee, Yunqin, June Ho Shin, Michelle Longmire, et al.. (2016). CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1. Clinical Cancer Research. 22(14). 3571–3581. 179 indexed citations
6.
Nguyen, Le Xuan Truong, et al.. (2016). Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells. Clinical Cancer Research. 22(13). 3320–3327. 25 indexed citations
7.
Lee, Yunqin & Subhra K. Biswas. (2016). Rewiring macrophages for anti-tumour immunity. Nature Cell Biology. 18(7). 718–720. 9 indexed citations
8.
Nguyen, Le Xuan Truong, Yunqin Lee, Lenore Urbani, et al.. (2015). Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1. Blood. 125(16). 2519–2529. 27 indexed citations
9.
Farnebo, Lovisa, Arash Shahangian, Yunqin Lee, et al.. (2015). Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma. Oncotarget. 6(12). 9897–9907. 28 indexed citations
10.
Lee, Yunqin & John B. Sunwoo. (2014). PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P270–P270. 13 indexed citations
11.
Lee, Yunqin, Manesh Chittezhath, Valentina Andrè, et al.. (2011). Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10. Blood. 119(1). 227–237. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026